| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield | 
|---|---|---|---|---|---|---|---|---|
| 31-Jul-21 | 952.60 | 265.20 | 140.40p | 11.0 | 0.1 | +88% | 60.00p | 3.9% | 
| 31-Jul-22 | 936.10 | 232.80 | 111.50p | 10.0 | n/a | -21% | 66.00p | 5.9% | 
| 31-Jul-23 | 932.60 | 112.00 | 55.10p | 16.7 | n/a | -51% | 67.50p | 7.3% | 
| 31-Jul-24 | 1,370.10 | 132.70 | 75.80¢ | 6.7 | 0.2 | +38% | n/a | 0.0% | 
| 31-Jul-25 | 1,305.90 | (122.40) | 59.30p | 6.8 | n/a | -22% | n/a | 0.0% | 
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield | 
|---|---|---|---|---|---|---|---|---|
| 31-Jul-26 | 706.08 | 174.27 | 46.33p | 9.0 | n/a | -22% | 2.00p | 0.0% | 
| 31-Jul-27 | 729.40 | 201.81 | 61.91p | 6.8 | 0.2 | +34% | 22.30p | 0.0% | 
| 31-Jul-28 | 713.49 | 284.50 | 83.42p | 5.0 | 0.1 | +35% | 28.72p | 0.0% | 
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
| 5 Yr High | 5 Yr Low | 5 Yr Avg | Curr / Avg | |
|---|---|---|---|---|
| Latest | 10.99 | 6.74 | 10.23 | 0.69 | 
Find out about IFRS and how this affects the financial infomation for all UK companies.
| Currency | UK Pounds | 
| Share Price | 418.80p | 
| Change Today | 0.80p | 
| % Change | 0.19 % | 
| 52 Week High | 550.50p | 
| 52 Week Low | 185.00p | 
| Volume | 73,140 | 
| Shares Issued | 150.52m | 
| Market Cap | £630.39m | 
| RiskGrade | 146 | 
| Value | 
		 | 
		
|---|
| Price Trend | 
		 | 
		
|---|
| Income | ![]()  | 
				
|---|
| Growth | 
		 | 
		
|---|
| Strong Buy | 3 | 
| Buy | 1 | 
| Neutral | 5 | 
| Sell | 1 | 
| Strong Sell | 0 | 
| Total | 10 | 

| Latest | Previous | |
|---|---|---|
| Final | Interim | |
| Ex-Div | 19-Oct-23 | 23-Mar-23 | 
| Paid | 24-Nov-23 | 26-Apr-23 | 
| Amount | 45.00p | 22.50p | 
| Time | Volume / Share Price | 
| 13:20 | 666 @ 418.38p | 
| 13:10 | 1 @ 418.80p | 
| 13:10 | 1 @ 418.80p | 
| 13:08 | 374 @ 418.40p | 
| 13:08 | 170 @ 418.40p | 
| Chair | Michael N Biggs | 
| CEO | Mike Morgan | 
You are here: research